APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sotalol Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sotalol Drug Market Outlook and Growth Opportunities 2026

20 December 2025191 pages

Choose your research edition.

Industry ResearchSotalol Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Sotalol Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Sotalol Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sotalol Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Sotalol Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sotalol Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sotalol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sotalol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sotalol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sotalol Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sotalol Drug market include AltaThera Pharmaceuticals, Apotex, Arbor Pharmaceuticals, Epic Pharma, Upsher-Smith Laboratories, Bayer HealthCare, Mylan and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sotalol Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sotalol Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sotalol Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sotalol Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Sotalol Drug Segment by Company

AltaThera Pharmaceuticals

Apotex

Arbor Pharmaceuticals

Epic Pharma

Upsher-Smith Laboratories

Bayer HealthCare

Mylan

Teva

Sotalol Drug Segment by Type

Injection

Tablet

Oral Solution

Sotalol Drug Segment by Application

Ventricular Arrhythmias

Supraventricular Arrhythmias

Sotalol Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Sotalol Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sotalol Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sotalol Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Sotalol Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotalol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sotalol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotalol Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sotalol Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sotalol Drug industry.

Chapter 3: Detailed analysis of Sotalol Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sotalol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sotalol Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sotalol Drug Industry Trends Table 2. Sotalol Drug Industry Drivers Table 3. Sotalol Drug Industry Opportunities and Challenges Table 4. Sotalol Drug Industry Restraints Table 5. Global Sotalol Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sotalol Drug Revenue Share by Company (2021-2026) Table 7. Global Sotalol Drug Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Sotalol Drug Sales Volume Share by Company (2021-2026) Table 9. Global Sotalol Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sotalol Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sotalol Drug Key Company Manufacturing Base & Headquarters Table 12. Global Sotalol Drug Company, Product Type & Application Table 13. Global Sotalol Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sotalol Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Tablet Table 19. Significant Companies of Oral Solution Table 20. Global Sotalol Drug Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Sotalol Drug Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Sotalol Drug Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Sotalol Drug Sales Volume Share by Type (2021-2026) Table 24. Global Sotalol Drug Sales Volume Share by Type (2027-2032) Table 25. Global Sotalol Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sotalol Drug Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Sotalol Drug Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Sotalol Drug Sales Value Share by Type (2021-2026) Table 29. Global Sotalol Drug Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Ventricular Arrhythmias Table 31. Significant Companies of Supraventricular Arrhythmias Table 32. Global Sotalol Drug Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Sotalol Drug Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Sotalol Drug Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Sotalol Drug Sales Volume Share by Application (2021-2026) Table 36. Global Sotalol Drug Sales Volume Share by Application (2027-2032) Table 37. Global Sotalol Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sotalol Drug Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sotalol Drug Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sotalol Drug Sales Value Share by Application (2021-2026) Table 41. Global Sotalol Drug Sales Value Share by Application (2027-2032) Table 42. Global Sotalol Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Sotalol Drug Sales by Region (2021-2026) & (W Units) Table 44. Global Sotalol Drug Sales Market Share by Region (2021-2026) Table 45. Global Sotalol Drug Sales by Region (2027-2032) & (W Units) Table 46. Global Sotalol Drug Sales Market Share by Region (2027-2032) Table 47. Global Sotalol Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sotalol Drug Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sotalol Drug Sales Value Share by Region (2021-2026) Table 50. Global Sotalol Drug Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sotalol Drug Sales Value Share by Region (2027-2032) Table 52. Global Sotalol Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Sotalol Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Sotalol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Sotalol Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sotalol Drug Sales by Country (2021-2026) & (W Units) Table 57. Global Sotalol Drug Sales Market Share by Country (2021-2026) Table 58. Global Sotalol Drug Sales by Country (2027-2032) & (W Units) Table 59. Global Sotalol Drug Sales Market Share by Country (2027-2032) Table 60. Global Sotalol Drug Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sotalol Drug Sales Value Market Share by Country (2021-2026) Table 62. Global Sotalol Drug Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sotalol Drug Sales Value Market Share by Country (2027-2032) Table 64. AltaThera Pharmaceuticals Company Information Table 65. AltaThera Pharmaceuticals Business Overview Table 66. AltaThera Pharmaceuticals Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. AltaThera Pharmaceuticals Sotalol Drug Product Portfolio Table 68. AltaThera Pharmaceuticals Recent Development Table 69. Apotex Company Information Table 70. Apotex Business Overview Table 71. Apotex Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Apotex Sotalol Drug Product Portfolio Table 73. Apotex Recent Development Table 74. Arbor Pharmaceuticals Company Information Table 75. Arbor Pharmaceuticals Business Overview Table 76. Arbor Pharmaceuticals Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Arbor Pharmaceuticals Sotalol Drug Product Portfolio Table 78. Arbor Pharmaceuticals Recent Development Table 79. Epic Pharma Company Information Table 80. Epic Pharma Business Overview Table 81. Epic Pharma Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Epic Pharma Sotalol Drug Product Portfolio Table 83. Epic Pharma Recent Development Table 84. Upsher-Smith Laboratories Company Information Table 85. Upsher-Smith Laboratories Business Overview Table 86. Upsher-Smith Laboratories Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Upsher-Smith Laboratories Sotalol Drug Product Portfolio Table 88. Upsher-Smith Laboratories Recent Development Table 89. Bayer HealthCare Company Information Table 90. Bayer HealthCare Business Overview Table 91. Bayer HealthCare Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bayer HealthCare Sotalol Drug Product Portfolio Table 93. Bayer HealthCare Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mylan Sotalol Drug Product Portfolio Table 98. Mylan Recent Development Table 99. Teva Company Information Table 100. Teva Business Overview Table 101. Teva Sotalol Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Teva Sotalol Drug Product Portfolio Table 103. Teva Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Sotalol Drug Distributors List Table 107. Sotalol Drug Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Sotalol Drug Product Image Figure 2. Global Sotalol Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sotalol Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sotalol Drug Sales (2021-2032) & (W Units) Figure 5. Global Sotalol Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sotalol Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Tablet Image Figure 11. Oral Solution Image Figure 12. Global Sotalol Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Sotalol Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Sotalol Drug Sales Volume Share by Type (2021-2032) Figure 15. Global Sotalol Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Sotalol Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Sotalol Drug Sales Value Share by Type (2021-2032) Figure 18. Ventricular Arrhythmias Image Figure 19. Supraventricular Arrhythmias Image Figure 20. Global Sotalol Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Sotalol Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sotalol Drug Sales Volume Share by Application (2021-2032) Figure 23. Global Sotalol Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sotalol Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sotalol Drug Sales Value Share by Application (2021-2032) Figure 26. Global Sotalol Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Sotalol Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sotalol Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sotalol Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sotalol Drug Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sotalol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sotalol Drug Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sotalol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sotalol Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sotalol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sotalol Drug Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sotalol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sotalol Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sotalol Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sotalol Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sotalol Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sotalol Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sotalol Drug Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sotalol Drug Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Oral Solution
Applications
  • Ventricular Arrhythmias
  • Supraventricular Arrhythmias
Companies covered
  • AltaThera Pharmaceuticals
  • Apotex
  • Arbor Pharmaceuticals
  • Epic Pharma
  • Upsher-Smith Laboratories
  • Bayer HealthCare
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sotalol Drug Sales Value (2021-2032)
  4. 1.2.2 Global Sotalol Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Sotalol Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sotalol Drug Market Dynamics
  1. 2.1 Sotalol Drug Industry Trends
  2. 2.2 Sotalol Drug Industry Drivers
  3. 2.3 Sotalol Drug Industry Opportunities and Challenges
  4. 2.4 Sotalol Drug Industry Restraints
3 Sotalol Drug Market by Company
  1. 3.1 Global Sotalol Drug Company Revenue Ranking in 2025
  2. 3.2 Global Sotalol Drug Revenue by Company (2021-2026)
  3. 3.3 Global Sotalol Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Sotalol Drug Average Price by Company (2021-2026)
  5. 3.5 Global Sotalol Drug Company Ranking (2024-2026)
  6. 3.6 Global Sotalol Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Sotalol Drug Company Product Type and Application
  8. 3.8 Global Sotalol Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sotalol Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sotalol Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sotalol Drug Market by Type
  1. 4.1 Sotalol Drug Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablet
  4. 4.1.3 Oral Solution
  5. 4.2 Global Sotalol Drug Sales Volume by Type
  6. 4.2.1 Global Sotalol Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sotalol Drug Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Sotalol Drug Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Sotalol Drug Sales Value by Type
  10. 4.3.1 Global Sotalol Drug Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Sotalol Drug Sales Value by Type (2021-2032)
  12. 4.3.3 Global Sotalol Drug Sales Value Share by Type (2021-2032)
5 Sotalol Drug Market by Application
  1. 5.1 Sotalol Drug Application Introduction
  2. 5.1.1 Ventricular Arrhythmias
  3. 5.1.2 Supraventricular Arrhythmias
  4. 5.2 Global Sotalol Drug Sales Volume by Application
  5. 5.2.1 Global Sotalol Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sotalol Drug Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sotalol Drug Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sotalol Drug Sales Value by Application
  9. 5.3.1 Global Sotalol Drug Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sotalol Drug Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sotalol Drug Sales Value Share by Application (2021-2032)
6 Sotalol Drug Regional Sales and Value Analysis
  1. 6.1 Global Sotalol Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sotalol Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Sotalol Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Sotalol Drug Sales by Region (2027-2032)
  5. 6.3 Global Sotalol Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sotalol Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sotalol Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sotalol Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Sotalol Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sotalol Drug Sales Value (2021-2032)
  12. 6.6.2 North America Sotalol Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sotalol Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Sotalol Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sotalol Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sotalol Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sotalol Drug Sales Value (2021-2032)
  21. 6.9.2 South America Sotalol Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sotalol Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sotalol Drug Sales Value Share by Country, 2025 VS 2032
7 Sotalol Drug Country-level Sales and Value Analysis
  1. 7.1 Global Sotalol Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sotalol Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sotalol Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Sotalol Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Sotalol Drug Sales by Country (2027-2032)
  6. 7.4 Global Sotalol Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sotalol Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sotalol Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sotalol Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sotalol Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sotalol Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sotalol Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sotalol Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sotalol Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sotalol Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sotalol Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sotalol Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sotalol Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sotalol Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sotalol Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sotalol Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sotalol Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sotalol Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sotalol Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sotalol Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sotalol Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sotalol Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sotalol Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sotalol Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sotalol Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sotalol Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sotalol Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sotalol Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sotalol Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sotalol Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sotalol Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sotalol Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sotalol Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sotalol Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AltaThera Pharmaceuticals
  2. 8.1.1 AltaThera Pharmaceuticals Company Information
  3. 8.1.2 AltaThera Pharmaceuticals Business Overview
  4. 8.1.3 AltaThera Pharmaceuticals Sotalol Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AltaThera Pharmaceuticals Sotalol Drug Product Portfolio
  6. 8.1.5 AltaThera Pharmaceuticals Recent Developments
  7. 8.2 Apotex
  8. 8.2.1 Apotex Company Information
  9. 8.2.2 Apotex Business Overview
  10. 8.2.3 Apotex Sotalol Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Apotex Sotalol Drug Product Portfolio
  12. 8.2.5 Apotex Recent Developments
  13. 8.3 Arbor Pharmaceuticals
  14. 8.3.1 Arbor Pharmaceuticals Company Information
  15. 8.3.2 Arbor Pharmaceuticals Business Overview
  16. 8.3.3 Arbor Pharmaceuticals Sotalol Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Arbor Pharmaceuticals Sotalol Drug Product Portfolio
  18. 8.3.5 Arbor Pharmaceuticals Recent Developments
  19. 8.4 Epic Pharma
  20. 8.4.1 Epic Pharma Company Information
  21. 8.4.2 Epic Pharma Business Overview
  22. 8.4.3 Epic Pharma Sotalol Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Epic Pharma Sotalol Drug Product Portfolio
  24. 8.4.5 Epic Pharma Recent Developments
  25. 8.5 Upsher-Smith Laboratories
  26. 8.5.1 Upsher-Smith Laboratories Company Information
  27. 8.5.2 Upsher-Smith Laboratories Business Overview
  28. 8.5.3 Upsher-Smith Laboratories Sotalol Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Upsher-Smith Laboratories Sotalol Drug Product Portfolio
  30. 8.5.5 Upsher-Smith Laboratories Recent Developments
  31. 8.6 Bayer HealthCare
  32. 8.6.1 Bayer HealthCare Company Information
  33. 8.6.2 Bayer HealthCare Business Overview
  34. 8.6.3 Bayer HealthCare Sotalol Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer HealthCare Sotalol Drug Product Portfolio
  36. 8.6.5 Bayer HealthCare Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Sotalol Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Sotalol Drug Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Teva
  44. 8.8.1 Teva Company Information
  45. 8.8.2 Teva Business Overview
  46. 8.8.3 Teva Sotalol Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Teva Sotalol Drug Product Portfolio
  48. 8.8.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sotalol Drug Value Chain Analysis
  2. 9.1.1 Sotalol Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sotalol Drug Sales Mode & Process
  6. 9.2 Sotalol Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sotalol Drug Distributors
  9. 9.2.3 Sotalol Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst